Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α
出版年份 2022 全文链接
标题
Combined Treatment of Tanshinone I and Epirubicin Revealed Enhanced Inhibition of Hepatocellular Carcinoma by Targeting PI3K/AKT/HIF-1α
作者
关键词
-
出版物
Drug Design Development and Therapy
Volume Volume 16, Issue -, Pages 3197-3213
出版商
Informa UK Limited
发表日期
2022-09-19
DOI
10.2147/dddt.s360691
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML
- (2021) Jacob Jalil Hassan et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tanshinone IIA inhibits gastric cancer cell stemness through inducing ferroptosis
- (2021) Haiwei Ni et al. ENVIRONMENTAL TOXICOLOGY
- Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial
- (2021) Osamu Aramaki et al. EUROPEAN JOURNAL OF CANCER
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
- (2021) Qi-Jiong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- Tanshinone I regulates autophagic signaling via the activation of AMP-activated protein kinase in cancer cells
- (2020) Lihua Zheng et al. ANTI-CANCER DRUGS
- Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53/DRAM-mediated autophagy in human hepatocellular carcinoma
- (2020) Xu Liu et al. Artificial Cells Nanomedicine and Biotechnology
- The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma
- (2020) Shunjie Xia et al. EBioMedicine
- Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway
- (2020) Peng Yuan et al. CELL BIOLOGY INTERNATIONAL
- SynergyFinder 2.0: visual analytics of multi-drug combination synergies
- (2020) Aleksandr Ianevski et al. NUCLEIC ACIDS RESEARCH
- The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients
- (2020) Li Fu et al. Frontiers in Pharmacology
- Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy
- (2020) Yan Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Effect of low-energy shock wave therapy on intravesical epirubicin delivery in a rat model of bladder cancer
- (2020) Ahmed Elkashef et al. BJU INTERNATIONAL
- Natural compound Tan-I enhances the efficacy of Paclitaxel chemotherapy in ovarian cancer
- (2020) Jin Zhou et al. Annals of Translational Medicine
- Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
- (2020) Xiaozhong Liao et al. Frontiers in Oncology
- Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan
- (2020) Chao-Chuan Wu et al. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Preventive and therapeutic role of Tanshinone ⅡA in hepatology
- (2019) Miao-Juan Shi et al. BIOMEDICINE & PHARMACOTHERAPY
- Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway
- (2019) Jin Zhou et al. CELL PROLIFERATION
- Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells
- (2018) Chien-Ming Chiu et al. OncoTargets and Therapy
- Arterial infusion of rapamycin in the treatment of rabbit hepatocellular carcinoma to improve the effect of TACE
- (2018) Tao Wu et al. Open Life Sciences
- Tanshinone I attenuates proliferation and chemoresistance of cervical cancer in a KRAS-dependent manner
- (2018) Sidi Dun et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines?
- (2018) Melody Xu et al. SEMINARS IN LIVER DISEASE
- The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
- (2017) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Tanshinone I induces apoptosis and pro-survival autophagy in gastric cancers
- (2016) Xiaoping Jing et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia
- (2016) S. S. Y. Lam et al. Science Translational Medicine
- Tanshinone IIA dampens the cell proliferation induced by ischemic insult in rat astrocytes via blocking the activation of HIF-1α/SDF-1 signaling
- (2014) Xiaojia Huang et al. LIFE SCIENCES
- Effect of lyophilized grapefruit juice on P-glycoprotein-mediated drug transportin-vitroandin-vivo
- (2013) Iman S. Ahmed et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma
- (2013) Guang-Zhi Jin et al. JOURNAL OF HEPATOLOGY
- Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
- (2012) Oktay Tacar et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- In vitro and in vivo multidrug resistance reversal activity by a Betti-base derivative of tylosin
- (2010) N Gyémánt et al. BRITISH JOURNAL OF CANCER
- Cepharanthine exerts antitumor activity on cholangiocarcinoma by inhibiting NF-κB
- (2010) Wunchana Seubwai et al. CANCER SCIENCE
- Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules
- (2008) I. T. Nizamutdinova et al. CARCINOGENESIS
- High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma
- (2008) Xiao-Dong Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started